Results 181 to 190 of about 14,731 (198)

Yttrium-90

Reactions Weekly, 2021
  +6 more sources

Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.

Journal of Vascular and Interventional Radiology, 2020
PURPOSE To evaluate outcomes of yttrium-90 radioembolization in patients with combined biphenotypic hepatocellular-cholangiocarcinoma (cHCC-CC). MATERIALS AND METHODS A retrospective review of patients with biopsy-confirmed cHCC-CC treated with yttrium-
C. Malone, W. Gibby, R. Tsai, S. Kim, S. Lancia, O. Akinwande, R. Ramaswamy   +6 more
semanticscholar   +1 more source

Collimator and energy window optimization for YTTRIUM-90 bremsstrahlung SPECT imaging.

Applied Radiation and Isotopes, 2020
The optimal collimator and energy window for Yttrium-90 bremsstrahlung SPECT imaging was investigated in the study. Yttrium-90 images were acquired with a dual-head gamma camera, equipped with parallel hole collimators and 90Y vial for different energy ...
Caner‐Veli Ince, Özlem Karadeniz, T. Ertay, H. Durak   +3 more
semanticscholar   +1 more source

Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.

Journal of Vascular and Interventional Radiology, 2019
PURPOSE To retrospectively assess the efficacy and safety of radioembolization with yttrium-90 (90Y) resin microspheres as a second-line option in patients with liver metastases from pancreatic adenocarcinoma.
A. Kim, S. Frantz, J. Brower, N. Akhter
semanticscholar   +1 more source

Yttrium 90

Reactions Weekly, 2018
  +5 more sources

Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases

European Journal of Nuclear Medicine and Molecular Imaging, 2021
S. Ebbers, C. van Roekel, M. Braat, M. Barentsz, M. Lam, A. Braat   +5 more
semanticscholar   +1 more source

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

The Lancet Oncology, 2017
V. Vilgrain, H. Pereira, E. Assenat, B. Guiu, Alina-Diana Ilonca, G. Pageaux, A. Sibert, M. Bouattour, R. Lebtahi, Wassim Allaham, H. Barraud, V. Laurent, E. Mathias, J. Bronowicki, J. Tasu, R. Perdrisot, C. Silvain, R. Gérolami, O. Mundler, J. Seitz, V. Vidal, C. Aubé, F. Oberti, O. Couturier, I. Brenot-Rossi, J. Raoul, A. Sarran, C. Costentin, E. Itti, A. Luciani, R. Adam, M. Lewin, D. Samuel, M. Ronot, Aurélia Dinut, L. Castéra, G. Chatellier   +36 more
semanticscholar   +1 more source

Yttrium-90 Radioembolization: Current Indications and Outcomes

Journal of Gastrointestinal Surgery, 2022
A. Hamad, H. Aziz, I. Kamel, D. Diaz, T. Pawlik   +4 more
semanticscholar   +1 more source

Yttrium-90

Reactions Weekly, 2023
openaire   +2 more sources

Yttrium-90

Reactions Weekly, 2011
openaire   +2 more sources